ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
profitability factor · long-only model fund

Foundry Gross Profitability Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FGPRHYPOTHETICAL MODEL
Since ’99
+878%
Expense Ratio
0.35%
placeholder
Holdings
213
cap-weighted
Inception
Jul 2020
placeholder
Full Sharpe
0.55
Ann. Return (LS)
9.9%
Ann. Volatility
18.1%
Max Drawdown
-38.7%
Test Sharpe ’19–26
0.98
Test FF5 α (ann.)
17.7%
vs Fama-French 5
Test FF5 α t-stat
3.43
significant (|t| ≥ 2)
Monthly turnover
8%
of the long leg, per rebalance
Cumulative return (LS)
878%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.73
what this fund holds
Long leg ann. return
11.3%
buyable, long-only
Long-short Sharpe
0.55
requires shorting
Bottom bucket ann. return
1.4%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

213 of 213 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
34.25%
2AAPL
APPLE INCTechnology$4.90T
34.20%
3LLY
ELI LILLY & COHealthcare$1.11T
7.75%
4MU
MICRON TECHNOLOGY INCTechnology$958.80B
6.69%
5LRCX
LAM RESEARCH CORPTechnology$391.80B
2.73%
6APP
APPLOVIN CORPTechnology$142.62B
1.00%
7SCCO
SOUTHERN COPPER CORPBasic Materials$142.48B
0.99%
8BKNG
BOOKING HOLDINGS INCIndustrials$140.78B
0.98%
9SBUX
STARBUCKS CORPConsumer Cyclical$120.23B
0.84%
10FTNT
FORTINET INCTechnology$118.40B
0.83%
11ADBE
ADOBE INCTechnology$94.31B
0.66%
12FDX
FEDEX CORPIndustrials$74.68B
0.52%
13CL
COLGATE PALMOLIVE COConsumer Defensive$74.40B
0.52%
14GWW
WW GRAINGER INCIndustrials$65.86B
0.46%
15ODFL
OLD DOMINION FREIGHT LINE INCIndustrials$48.63B
0.34%
16IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.31%
17NTRA
NATERA INCHealthcare$38.87B
0.27%
18ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.25%
19ONC
BEONE MEDICINES LTDHealthcare$34.68B
0.24%
20UI
UBIQUITI INCTechnology$33.04B
0.23%
21ZTS
ZOETIS INCHealthcare$32.10B
0.22%
22FICO
FAIR ISAAC CORPTechnology$29.15B
0.20%
23TPR
TAPESTRY INCConsumer Cyclical$28.58B
0.20%
24JBHT
HUNT J B TRANSPORT SERVICES INCIndustrials$27.48B
0.19%
25MTD
METTLER TOLEDO INTERNATIONAL INCHealthcare$26.47B
0.18%
26VRSN
VERISIGN INCTechnology$25.27B
0.18%
27XPO
XPO INCIndustrials$25.25B
0.18%
28EXPD
EXPEDITORS INTERNATIONAL OF WASHINGTON INCIndustrials$23.91B
0.17%
29TEAM
ATLASSIAN CORPTechnology$23.67B
0.17%
30LUV
SOUTHWEST AIRLINES COIndustrials$23.50B
0.16%
31INCY
INCYTE CORPHealthcare$23.42B
0.16%
32P
EVERPURE INCTechnology$23.06B
0.16%
33ROKU
ROKU INCCommunication Services$21.32B
0.15%
34NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.12%
35THC
TENET HEALTHCARE CORPHealthcare$16.79B
0.12%
36NTNX
NUTANIX INCTechnology$14.89B
0.10%
37EXEL
EXELIXIS INCHealthcare$14.06B
0.10%
38PINS
PINTEREST INCCommunication Services$13.00B
0.09%
39MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.09%
40DKNG
DRAFTKINGS INCConsumer Cyclical$12.37B
0.09%
41IESC
IES HOLDINGS INCIndustrials$12.21B
0.09%
42AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.08%
43W
WAYFAIR INCConsumer Cyclical$11.79B
0.08%
44SAIA
SAIA INCIndustrials$11.65B
0.08%
45HUBS
HUBSPOT INCTechnology$11.49B
0.08%
46PODD
INSULET CORPHealthcare$11.36B
0.08%
47CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.08%
48DPZ
DOMINOS PIZZA INCConsumer Cyclical$10.72B
0.07%
49AYI
ACUITY INC (DE)Industrials$9.99B
0.07%
50CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.07%
51MANH
MANHATTAN ASSOCIATES INCTechnology$9.66B
0.07%
52HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.06%
53CHWY
CHEWY INCConsumer Cyclical$8.57B
0.06%
54ETSY
ETSY INCConsumer Cyclical$7.98B
0.06%
55HIMS
HIMS & HERS HEALTH INCConsumer Defensive$7.60B
0.05%
56RSI
RUSH STREET INTERACTIVE INCConsumer Cyclical$7.56B
0.05%
57ACI
ALBERTSONS COMPANIES INCConsumer Defensive$7.47B
0.05%
58RYTM
RHYTHM PHARMACEUTICALS INCHealthcare$7.31B
0.05%
59MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.05%
60LQDA
LIQUIDIA CORPHealthcare$7.11B
0.05%
61MSM
MSC INDUSTRIAL DIRECT CO INCIndustrials$6.97B
0.05%
62HNGE
HINGE HEALTH INCHealthcare$6.74B
0.05%
63APPF
APPFOLIO INCTechnology$6.36B
0.04%
64SEZL
SEZZLE INCFinancial Services$5.87B
0.04%
65PEGA
PEGASYSTEMS INCTechnology$5.39B
0.04%
66TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.04%
67RELY
REMITLY GLOBAL INCTechnology$5.08B
0.04%
68PTRN
PATTERN GROUP INCConsumer Cyclical$4.97B
0.03%
69KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.03%
70SITE
SITEONE LANDSCAPE SUPPLY INCIndustrials$4.60B
0.03%
71ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.03%
72RHI
ROBERT HALF INCIndustrials$4.28B
0.03%
73ANF
ABERCROMBIE & FITCH COConsumer Cyclical$4.23B
0.03%
74BOX
BOX INCTechnology$4.22B
0.03%
75EXTR
EXTREME NETWORKS INCTechnology$3.97B
0.03%
76WING
WINGSTOP INCConsumer Cyclical$3.88B
0.03%
77YETI
YETI HOLDINGS INCConsumer Cyclical$3.87B
0.03%
78CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.03%
79ADPT
ADAPTIVE BIOTECHNOLOGIES CORPHealthcare$3.67B
0.03%
80NHC
NATIONAL HEALTHCARE CORPHealthcare$3.56B
0.02%
81ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.02%
82RNG
RINGCENTRAL INCTechnology$3.46B
0.02%
83WDFC
WD 40 COBasic Materials$3.31B
0.02%
84WRBY
WARBY PARKER INCHealthcare$3.24B
0.02%
85CARG
CARGURUS INCConsumer Cyclical$3.16B
0.02%
86SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.02%
87GRND
GRINDR INCTechnology$2.71B
0.02%
88TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.02%
89CALX
CALIX INCTechnology$2.50B
0.02%
90CMPR
CIMPRESS PLCCommunication Services$2.49B
0.02%
91BLBD
BLUE BIRD CORPConsumer Cyclical$2.48B
0.02%
92VCEL
VERICEL CORPHealthcare$2.38B
0.02%
93BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.02%
94AXGN
AXOGEN INCHealthcare$2.12B
0.01%
95CDNA
CAREDX INCHealthcare$2.05B
0.01%
96SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.01%
97ADMA
ADMA BIOLOGICS INCHealthcare$2.02B
0.01%
98URGN
UROGEN PHARMA LTDHealthcare$1.96B
0.01%
99HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.01%
100APPN
APPIAN CORPTechnology$1.92B
0.01%
101SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.01%
102NVCR
NOVOCURE LTDHealthcare$1.84B
0.01%
103SONO
SONOS INCTechnology$1.80B
0.01%
104FLO
FLOWERS FOODS INCConsumer Defensive$1.80B
0.01%
105ASAN
ASANA INCTechnology$1.77B
0.01%
106ATRC
ATRICURE INCHealthcare$1.77B
0.01%
107HROW
HARROW INCHealthcare$1.74B
0.01%
108TDOC
TELADOC HEALTH INCHealthcare$1.70B
0.01%
109ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.01%
110IDT
IDT CORPCommunication Services$1.57B
0.01%
111XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.01%
112INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.01%
113YELP
YELP INCCommunication Services$1.44B
0.01%
114AIP
ARTERIS INCTechnology$1.43B
0.01%
115BJRI
BJS RESTAURANTS INCConsumer Cyclical$1.42B
0.01%
116BRBR
BELLRING BRANDS INCConsumer Defensive$1.41B
0.01%
117OMDA
OMADA HEALTH INCHealthcare$1.41B
0.01%
118WINA
WINMARK CORPConsumer Cyclical$1.39B
0.01%
119LINC
LINCOLN EDUCATIONAL SERVICES CORPConsumer Defensive$1.36B
0.01%
120REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.01%
121NVAX
NOVAVAX INCHealthcare$1.35B
0.01%
122LZ
LEGALZOOMCOM INCIndustrials$1.33B
0.01%
123GIC
GLOBAL INDUSTRIAL COIndustrials$1.32B
0.01%
124DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.01%
125ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.01%
126UPBD
UPBOUND GROUP INCTechnology$1.29B
0.01%
127NSSC
NAPCO SECURITY TECHNOLOGIES INCIndustrials$1.29B
0.01%
128ARDX
ARDELYX INCHealthcare$1.28B
0.01%
129HLF
HERBALIFE LTDConsumer Defensive$1.24B
0.01%
130CBRL
CRACKER BARREL OLD COUNTRY STORE INCConsumer Cyclical$1.20B
0.01%
131XPEL
XPEL INCConsumer Cyclical$1.19B
0.01%
132ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.01%
133PXED
PHOENIX EDUCATION PARTNERS INCConsumer Defensive$1.09B
0.01%
134GRPN
GROUPON INCCommunication Services$1.06B
0.01%
135KFRC
KFORCE INCIndustrials$1.04B
0.01%
136PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.01%
137APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.01%
138EVER
EVERQUOTE INCCommunication Services$925M
0.01%
139RDVT
RED VIOLET INCTechnology$920M
0.01%
140TALK
TALKSPACE INCHealthcare$873M
0.01%
141PHAT
PHATHOM PHARMACEUTICALS INCHealthcare$873M
0.01%
142TDUP
THREDUP INCConsumer Cyclical$852M
0.01%
143SIBN
SI-BONE INCHealthcare$771M
0.01%
144KRT
KARAT PACKAGING INCConsumer Cyclical$760M
0.01%
145DSP
VIANT TECHNOLOGY INCTechnology$754M
0.01%
146RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.01%
147MAMA
MAMA'S CREATIONS INCConsumer Defensive$700M
0.00%
148TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.00%
149NRDS
NERDWALLET INCCommunication Services$609M
0.00%
150GYRE
GYRE THERAPEUTICS INCHealthcare$587M
0.00%
151MYGN
MYRIAD GENETICS INCHealthcare$584M
0.00%
152VITL
VITAL FARMS INCConsumer Defensive$581M
0.00%
153WEAV
WEAVE COMMUNICATIONS INCHealthcare$575M
0.00%
154OOMA
OOMA INCCommunication Services$568M
0.00%
155ANGO
ANGIODYNAMICS INCHealthcare$558M
0.00%
156NPCE
NEUROPACE INCHealthcare$548M
0.00%
157SPT
SPROUT SOCIAL INCTechnology$518M
0.00%
158LWAY
LIFEWAY FOODS INCConsumer Defensive$488M
0.00%
159OFIX
ORTHOFIX MEDICAL INCHealthcare$468M
0.00%
160VMD
VIEMED HEALTHCARE INCHealthcare$466M
0.00%
161DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.00%
162PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
163BBW
BUILD-A-BEAR WORKSHOP INCConsumer Cyclical$428M
0.00%
164QMCO
QUANTUM CORPTechnology$419M
0.00%
165USNA
USANA HEALTH SCIENCES INCConsumer Defensive$403M
0.00%
166NATH
NATHANS FAMOUS INCConsumer Cyclical$393M
0.00%
167EOLS
EVOLUS INCHealthcare$377M
0.00%
168FENC
FENNEC PHARMACEUTICALS INCHealthcare$365M
0.00%
169NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
170ELMD
ELECTROMED INCHealthcare$349M
0.00%
171XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.00%
172VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.00%
173BKKT
BAKKT INCTechnology$323M
0.00%
174MKTW
MARKETWISE INCTechnology$314M
0.00%
175BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
176OFLX
OMEGA FLEX INCIndustrials$302M
0.00%
177UCFI
CN HEALTHY FOOD TECH GROUP CORPConsumer Defensive$288M
0.00%
178SGHT
SIGHT SCIENCES INCHealthcare$274M
0.00%
179TBCH
TURTLE BEACH CORPTechnology$258M
0.00%
180QTTB
Q32 BIO INCHealthcare$255M
0.00%
181NUS
NU SKIN ENTERPRISES INCConsumer Defensive$254M
0.00%
182CXDO
CREXENDO INCCommunication Services$248M
0.00%
183JILL
JJILL INCConsumer Cyclical$248M
0.00%
184SMTI
SANARA MEDTECH INCHealthcare$229M
0.00%
185FC
FRANKLIN COVEY COIndustrials$229M
0.00%
186SPOK
SPOK HOLDINGS INCHealthcare$222M
0.00%
187KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
188AGEN
AGENUS INCHealthcare$209M
0.00%
189BDSX
BIODESIX INCHealthcare$204M
0.00%
190DERM
JOURNEY MEDICAL CORPHealthcare$197M
0.00%
191INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
192MRDN
MERIDIAN HOLDINGS INCCommunication Services$171M
0.00%
193OWLT
OWLET INCHealthcare$162M
0.00%
194RCEL
AVITA MEDICAL INCHealthcare$157M
0.00%
195OCC
OPTICAL CABLE CORPTechnology$130M
0.00%
196CUE
CUE BIOPHARMA INCHealthcare$126M
0.00%
197INSG
INSEEGO CORPTechnology$122M
0.00%
198AKA
AKA BRANDS HOLDING CORPConsumer Cyclical$119M
0.00%
199MED
MEDIFAST INCConsumer Cyclical$114M
0.00%
200TZOO
TRAVELZOOCommunication Services$113M
0.00%
201CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
202VRCA
VERRICA PHARMACEUTICALS INCHealthcare$96M
0.00%
203SOTK
SONO TEK CORPTechnology$86M
0.00%
204CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
205AEYE
AUDIOEYE INCTechnology$82M
0.00%
206BARK
BARK INCConsumer Cyclical$82M
0.00%
207LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
208SEAT
VIVID SEATS INCCommunication Services$78M
0.00%
209AIRG
AIRGAIN INCTechnology$76M
0.00%
210ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
211BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
212WFCF
WHERE FOOD COMES FROM INCTechnology$63M
0.00%
213SNWV
SANUWAVE HEALTH INCHealthcare$55M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $14.33T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

9 sectors
Technology
81.9%
Healthcare
10.9%
Industrials
3.4%
Consumer Cyclical
1.8%
Basic Materials
1.0%
Consumer Defensive
0.7%
Communication Services
0.3%
Financial Services
0.0%
Energy
0.0%

Portfolio Style

Size × value map of the long-leg book

213 classified
Value
Blend
Growth
Large
Mid
Small
1%3
9%14
88%44
<1%8
<1%21
1%36
<1%14
<1%23
<1%23

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 94% toward Growth. +1% unclassified (27 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt94% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 213 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    37.1%
    Margin
    -37.9%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    34.2%
    Margin
    -9.2%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    41.2%
    Margin
    -16.2%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied
  • At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.

    Required
    >= 50.0%
    Actual
    37.1%
    Margin
    -12.9%

    Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 213 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.1 (95% CI 0.8-1.2)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
10.3%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.07x
within
parametric
0.96x
within
cornish fisher
0.92x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2013
Before publication (pre-2013)
0.39
Sharpe · 7.8% p.a.
January 1999December 2013 · 180 mo
Since publication
0.78
Sharpe · 12.4% p.a.
January 2014July 2026 · 151 mo
Change in Sharpe+0.39Sharpe strengthened since publication58% stronger in annual return

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
73%
19 of 26 3-year windows made money
Worst window
-0.78
Sharpe, January 2003 – December 2005
January 1999July 2026
Median Sharpe
0.72
Dispersion
0.59
Best window
1.44

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.17.4%31.8%
3 yearsp.a.31.6%29.1%
5 yearsp.a.16.8%23.3%
10 yearsp.a.14.9%12.3%
Since inceptionp.a.10.5%8.6%
Calendar years
YearLong legLong-short
20267 mo4.8%14.3%
202525.0%25.6%
202460.4%40.7%
202327.6%7.0%
2022-22.1%14.2%
202118.3%8.9%
202021.6%12.1%
201926.4%6.3%
2018-5.0%14.1%
20172.5%-18.8%
20168.5%-4.4%
20150.9%17.5%
201414.4%21.2%
201334.0%5.4%
201210.6%2.7%
20111.0%-4.2%
201022.2%-0.1%
200933.7%-4.0%
2008-24.6%37.9%
20074.0%-3.6%
200612.0%0.8%
20053.5%0.7%
200423.0%-1.6%
200321.0%-23.0%
2002-16.5%16.3%
2001-15.5%7.8%
200024.0%123.2%
199918.2%-15.0%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FGPR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2020-07-10 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$14.33T

Methodology

The Foundry Gross Profitability Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Gross Profitability signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.